Morgan Stanley (MS) Stock Price & How to Invest

Morgan Stanley is a global financial services firm founded in 1935 and headquartered in New York City, with offices in 42 countries and more than 80,000 employees. It operates through three segments: Institutional Securities (investment banking, equity and fixed-income trading, prime brokerage, and research), Wealth Management (financial-advisor-led brokerage, investment advisory, lending, and banking services for individuals and families), and Investment Management (equity, fixed income, alternatives, and liquidity strategies for institutions and intermediaries). The firm earns revenue through advisory and underwriting fees, trading gains, and, increasingly, recurring asset-based fees tied to the value of client assets across its wealth and investment management platforms. The current Morgan Stanley took its modern shape through the 1997 merger with Dean Witter Discover and a string of subsequent acquisitions, most notably E*TRADE (2020) and Eaton Vance (2021), which dramatically expanded its self-directed brokerage and asset management capabilities. Ted Pick became Chairman and CEO at the start of 2024, succeeding James Gorman, who had led the firm since 2010 and orchestrated its transformation toward fee-based businesses. Under Pick, the integrated-firm strategy emphasizes cross-selling across all three segments and driving client assets toward fee-based relationships to generate more predictable earnings.

A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. Regulatory capital requirements remain an ongoing headwind, with Basel-related rules potentially requiring the firm to hold more capital against trading and lending exposures, constraining returns. Morgan Stanley's stock also carries a beta above 1.0, meaning it tends to move more than the broader market in both directions, so sharp equity-market selloffs can produce outsized drawdowns. Finally, a structural decline in equity underwriting volumes over a prolonged period would disproportionately affect a firm that has historically ranked as a top equity underwriter globally.

21 analysts publish price targets on MS, averaging $236.38 against a $210.42 price as of August 2026, or +12.3%. The published targets run from $184.00 to $262.00, a moderate spread, and the ratings split 11 buy, 13 hold, 1 sell. Over the last six months there have been 12 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full MS forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Morgan Stanley. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Wealth management as a recurring-revenue engine. Wealth Management generated roughly 50 percent of total firm revenues in fiscal 2025, anchoring profitability with fee income tied to client assets rather than market transactions. The most optimistic published target, $262.00, assumes this works close to its best case.

The case against. A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. The most pessimistic target, $184.00, is roughly what MS is worth if this bites instead.

Read the full bull and bear case on MS, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Morgan Stanley's investor relations page or your broker.

• Revenue (Full Year 2025): ~$70.6 billion
• Net Income (Full Year 2025): ~$13.4 billion (approx., based on ~$10.21 EPS on ~1.58B diluted shares)
• EPS (TTM): ~$11.04
• P/E Ratio (TTM): ~19-20x
• Forward P/E: ~17.6x
• Market Capitalization: ~$334 billion
• Return on Tangible Common Equity (Full Year 2025): ~21.6%
• Annual Dividend Per Share: ~$4.00 (dividend yield ~1.9%)

Morgan Stanley's trailing P/E of roughly 19 to 20 times sits modestly above its own 5-year historical average of around 14 to 15 times, reflecting the market's recognition of the firm's successful shift toward more durable, fee-based earnings. The ROTCE of 21.6% for full-year 2025 demonstrates that the integrated-firm model is generating returns well above most peers' cost of equity, though sustaining that level depends on continued strength in both capital markets and wealth inflows. At a forward P/E of approximately 17.6 times, the stock is not priced as a deep-value name, meaning expectations for continued earnings growth are already embedded in the current price.

If you want MS exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

These are the investment theses MS naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Other names that sit close to MS: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get MS exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (PFF, XLF, PFFD), which spreads the position across many companies. Or build it into a focused thematic portfolio, so MS sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where MS fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Morgan Stanley is today primarily a wealth and asset management powerhouse that still carries a premier investment bank inside it, reporting $70.6 billion in full-year 2025 net revenues and a return on tangible common equity of 21.6%. If you believe that a multi-decade global wealth accumulation trend, a recovering deal cycle, and recurring fee income create a structurally higher earnings floor, the question becomes sizing and overlap with other financials in your portfolio, not timing. The risk is that a severe or prolonged market downturn compresses both asset-based wealth fees and capital-markets activity at the same time, hitting both of the firm's major engines at once.

Whether MS is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is MS a buy or a sell?, and where the stock could go from here in the MS stock forecast.

For income investors, whether MS pays a dividend and how the payout looks is covered in does MS pay a dividend? And to weigh MS against a peer, read the full side-by-side comparisons: MS vs AXP and MS vs BAC.